TCL Archive Volasertib Shows Response In 31 Percent of Acute Myeloid Leukemia Patients December 28, 2012
TCL Archive ImClone Founding CEO Samuel Waksal Charged With Securities Fraud, Conspiracy, Perjury June 14, 2002
TCL Archive Clinical Trial Participants Sue Duke University, Potti, Nevins and Others for Causing Harm September 9, 2011